-
Study aim
-
Determining the effect of hydro alcoholic extract of Elaeagnus angustifolia L. on women's sexual performance
-
Design
-
A clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 58 patients, a computer site is used for randomization
-
Settings and conduct
-
The location is Masoumeh Hospital, Kermanshah. After the patients are allowed to participate in the study, the subjects are randomly assigned to the intervention and treatment group, and the intervention subjects take one cc of medicine and the placebo subjects take 1 cc of placebo daily. drugs will be placed in sealed envelopes with predetermined codes by a person who is not involved in providing the treatment.
-
Participants/Inclusion and exclusion criteria
-
Married women aged 18 to 54 with a complaint of decreased sexual performance and a score of less than 28 from the sexual performance questionnaire conditions of non-entry include pregnancy and breastfeeding, oophorectomy, menopause, the use of some hormone-based drugs, or the individual's unwillingness to continue participating in the study
-
Intervention groups
-
The intervention is the hydro alcoholic extract of Elaeagnus angustifolia L. and the intervention group will consume one cc equivalent to 20 drops of the medicine daily for 30 days, and the people in the control group will also consume one cc of the placebo daily for 30 days.
-
Main outcome variables
-
The main variable of the questionnaire is the sexual function, which has 6 fields, including the fields of desire, slippery, arousal, satisfaction, orgasm, and pain. The changes in scores will be checked once overall and once in the desired areas before the intervention and once after taking the drug at the end of the study.
Progesterone and estrogen hormone changes will be checked once before taking the drug and once after taking the drug